QuiVad

Home / Funds / Mangrove Partners

Mangrove Partners

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Aeluma, INC.Germany1.35%July 21, 2026
Iperionx LtdGermany1.06%April 17, 2025

History of disclosures

22 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
July 21, 2026Aeluma, INC.Germany1.35%still open
April 17, 2025Iperionx LtdGermany1.06%still open
March 14, 2022Mycronic AB (publ)Sweden0.00%still open
October 22, 2021Oncopeptides ABSweden0.00%still open
October 11, 2021Oncopeptides ABSweden0.73%still open
October 8, 2021Oncopeptides ABSweden0.93%still open
September 17, 2021Oncopeptides ABSweden1.10%still open
September 13, 2021Oncopeptides ABSweden1.00%still open
September 8, 2021Oncopeptides ABSweden0.96%still open
August 4, 2021Oncopeptides ABSweden0.84%still open
July 13, 2021Oncopeptides ABSweden0.79%still open
July 9, 2021Oncopeptides ABSweden0.58%still open
February 3, 2021Mycronic AB (publ)Sweden0.57%still open
January 28, 2021Mycronic AB (publ)Sweden0.76%still open
January 21, 2021Mycronic AB (publ)Sweden0.82%still open
January 19, 2021Mycronic AB (publ)Sweden0.95%still open
January 18, 2021Mycronic AB (publ)Sweden1.08%still open
December 18, 2020Mycronic AB (publ)Sweden1.18%still open
December 15, 2020Mycronic AB (publ)Sweden1.27%still open
December 9, 2020Mycronic AB (publ)Sweden1.39%still open
July 22, 2020Mycronic AB (publ)Sweden1.48%still open
May 5, 2020Mycronic AB (publ)Sweden1.59%still open

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Mangrove Partners, data as at July 21, 2026, https://www.quivad.com/detenteur/mangrove-partners